V I Reus

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Antiglucocorticoid treatments in psychiatry
    V I Reus
    University of California, San Francisco, School of Medicine, Department of Psychiatry 94143 0984, USA
    Psychoneuroendocrinology 22:S121-4. 1997
  2. ncbi request reprint Antiglucocorticoid drugs in the treatment of depression
    V I Reus
    Department of Psychiatry, Center on Neurobiology and Behavior, University of California, San Francisco, School of Medicine, 401 Parnassus Avenue, Box F 0984, CA 94143 0984, USA
    Expert Opin Investig Drugs 10:1789-96. 2001
  3. ncbi request reprint Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study
    S M Hall
    Department of Psychology, University of California, San Francisco, USA
    J Consult Clin Psychol 64:1003-9. 1996
  4. ncbi request reprint Double-blind treatment of major depression with dehydroepiandrosterone
    O M Wolkowitz
    Department of Psychiatry, University of California Medical Center, San Francisco, USA
    Am J Psychiatry 156:646-9. 1999
  5. pmc Dysregulated relationship of inflammation and oxidative stress in major depression
    B J Rawdin
    Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA
    Brain Behav Immun 31:143-52. 2013
  6. ncbi request reprint Treatment of depression with antiglucocorticoid drugs
    O M Wolkowitz
    Department of Psychiatry, University of California, San Francisco, School of Medicine 94143 0984, USA
    Psychosom Med 61:698-711. 1999
  7. ncbi request reprint Stress hormone-related psychopathology: pathophysiological and treatment implications
    O M Wolkowitz
    Department of Psychiatry, University of California, School of Medicine, San Francisco, USA
    World J Biol Psychiatry 2:115-43. 2001
  8. pmc Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response
    O M Wolkowitz
    Department of Psychiatry, School of Medicine, University of California, San Francisco UCSF, San Francisco, CA 94143 0984, USA
    Mol Psychiatry 17:164-72. 2012
  9. doi request reprint Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic
    D K Hatsukami
    Department of Psychiatry, University of Minnesota Tobacco Use Programs, Minneapolis, Minnesota, USA
    Clin Pharmacol Ther 89:392-9. 2011
  10. ncbi request reprint Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients
    D S Harris
    Department of Psychiatry, Box CPR 0984, University of California, San Francisco Medical Center, 401 Parnassus Ave, San Francisco, CA 94143 0984, USA
    World J Biol Psychiatry 2:99-102. 2001

Collaborators

Detail Information

Publications38

  1. ncbi request reprint Antiglucocorticoid treatments in psychiatry
    V I Reus
    University of California, San Francisco, School of Medicine, Department of Psychiatry 94143 0984, USA
    Psychoneuroendocrinology 22:S121-4. 1997
    ..The data thus far suggest that antiglucocorticoid drug treatment may be useful in certain subgroups of depressed patients and may offer a theoretical rationale for alternative drug design...
  2. ncbi request reprint Antiglucocorticoid drugs in the treatment of depression
    V I Reus
    Department of Psychiatry, Center on Neurobiology and Behavior, University of California, San Francisco, School of Medicine, 401 Parnassus Avenue, Box F 0984, CA 94143 0984, USA
    Expert Opin Investig Drugs 10:1789-96. 2001
    ....
  3. ncbi request reprint Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study
    S M Hall
    Department of Psychology, University of California, San Francisco, USA
    J Consult Clin Psychol 64:1003-9. 1996
    ..History-positive smokers may be best treated by interventions providing additional support and contact, independent of therapeutic content...
  4. ncbi request reprint Double-blind treatment of major depression with dehydroepiandrosterone
    O M Wolkowitz
    Department of Psychiatry, University of California Medical Center, San Francisco, USA
    Am J Psychiatry 156:646-9. 1999
    ..This study was designed to assess possible antidepressant effects of dehydroepiandrosterone (DHEA), an abundant adrenocortical hormone in humans...
  5. pmc Dysregulated relationship of inflammation and oxidative stress in major depression
    B J Rawdin
    Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA
    Brain Behav Immun 31:143-52. 2013
    ..These findings may help explain the increased risk of comorbid medical illnesses in MDD...
  6. ncbi request reprint Treatment of depression with antiglucocorticoid drugs
    O M Wolkowitz
    Department of Psychiatry, University of California, San Francisco, School of Medicine 94143 0984, USA
    Psychosom Med 61:698-711. 1999
    ..The theoretical and empirical rationales for the potential therapeutic use of antiglucocorticoid agents in the treatment of depression are reviewed...
  7. ncbi request reprint Stress hormone-related psychopathology: pathophysiological and treatment implications
    O M Wolkowitz
    Department of Psychiatry, University of California, School of Medicine, San Francisco, USA
    World J Biol Psychiatry 2:115-43. 2001
    ..We then review certain clinical manifestations of such hormonal imbalances and discuss pharmacological and behavioural treatment strategies aimed at normalizing hormonal output and lessening psychiatric and physical pathology...
  8. pmc Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response
    O M Wolkowitz
    Department of Psychiatry, School of Medicine, University of California, San Francisco UCSF, San Francisco, CA 94143 0984, USA
    Mol Psychiatry 17:164-72. 2012
    ..PBMC telomerase activity might reflect a novel aspect of depressive pathophysiology and might represent a novel biomarker of antidepressant responsiveness...
  9. doi request reprint Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic
    D K Hatsukami
    Department of Psychiatry, University of Minnesota Tobacco Use Programs, Minneapolis, Minnesota, USA
    Clin Pharmacol Ther 89:392-9. 2011
    ..Its further development as a treatment for nicotine dependence is therefore justified...
  10. ncbi request reprint Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients
    D S Harris
    Department of Psychiatry, Box CPR 0984, University of California, San Francisco Medical Center, 401 Parnassus Ave, San Francisco, CA 94143 0984, USA
    World J Biol Psychiatry 2:99-102. 2001
    ....
  11. ncbi request reprint Glucocorticoid medication, memory and steroid psychosis in medical illness
    O M Wolkowitz
    Department of Psychiatry, University of California Medical Center San Francisco 94143, USA
    Ann N Y Acad Sci 823:81-96. 1997
    ....
  12. ncbi request reprint Cultural influences on diagnosis and perception of Tourette syndrome in Costa Rica
    C A Mathews
    Department of Psychiatry, University of California at San Francisco, 401 Parnassus Avenue, Box NGL 0984, San Francisco, CA 94143, USA
    J Am Acad Child Adolesc Psychiatry 40:456-63. 2001
    ..This study examines the phenomenology and presentation of TS in Costa Rica...
  13. ncbi request reprint Cortisol levels predict cognitive impairment induced by electroconvulsive therapy
    T C Neylan
    Department of Psychiatry, University of California, San Francisco, CA 94121, USA
    Biol Psychiatry 50:331-6. 2001
    ....
  14. ncbi request reprint DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study
    O M Wolkowitz
    Department of Psychiatry, Center for Neurobiology and Psychiatry, University of California San Francisco UCSF School of Medicine, USA
    Neurology 60:1071-6. 2003
    ..To compare the efficacy and tolerability of dehydroepiandrosterone (DHEA) vs placebo in AD...
  15. ncbi request reprint Development of major depression after treatment for smoking cessation
    J Y Tsoh
    Department of Psychiatry, University of California, San Francisco 94143, USA
    Am J Psychiatry 157:368-74. 2000
    ..Case studies suggest cigarette abstinence may precipitate a major depressive episode. This study examined the incidence and predictors of major depression in the 12 months after treatment for smoking cessation...
  16. ncbi request reprint Assortative mating in the affective disorders: a systematic review and meta-analysis
    C A Mathews
    Department of Psychiatry, University of California at San Francisco, 94143, USA
    Compr Psychiatry 42:257-62. 2001
    ..These results support the previously reported findings, and may have important implications for genetic studies...
  17. ncbi request reprint Association between maternal smoking and increased symptom severity in Tourette's syndrome
    Carol A Mathews
    Department of Psychiatry, University of California San Diego, La Jolla, CA, and the Department of Psychiatry, North Shore University Hospital New York University School of Medicine, Manhasset, NY, USA
    Am J Psychiatry 163:1066-73. 2006
    ....
  18. ncbi request reprint Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation
    Sharon M Hall
    Department of Psychiatry, University of California, San Francisco, 94143, USA
    J Behav Health Serv Res 32:381-92. 2005
    ..Prospective investigations of the cost and cost-effectiveness of psychological and pharmacological intervention, using adequate sample sizes, are warranted...
  19. ncbi request reprint Repeated psychological stress testing in stimulant-dependent patients
    Debra S Harris
    Drug Dependence Research Center, Langley Porter Psychiatric Institute, Department of Psychiatry, University of California, San Francisco, CA, USA
    Prog Neuropsychopharmacol Biol Psychiatry 29:669-77. 2005
    ..Although less convincing because of the heterogeneity of the subjects, they also suggest that HPA axis responsivity is not clearly linked to acute stress-induced stimulant craving or affective response...
  20. ncbi request reprint Heritability and clinical features of multigenerational families with obsessive-compulsive disorder and hoarding
    Carol A Mathews
    Department of Psychiatry, University of California, San Francisco, San Francisco, California 94143 0984, USA
    Am J Med Genet B Neuropsychiatr Genet 144:174-82. 2007
    ..39 for hoarding. We found reasonable power to detect regions of interest (lod = 2) for OCD in these families, but will need to expand our family collection to have adequate power to detect regions of interest for hoarding...
  21. ncbi request reprint Varenicline: new treatment with efficacy in smoking cessation
    Victor I Reus
    Department of Psychiatry, University of California School of Medicine, San Francisco, California 94143 0984, USA
    Drugs Today (Barc) 43:65-75. 2007
    ..Its targeted mechanism of action, superior efficacy and excellent tolerability make varenicline a welcome and useful addition to the therapeutic options for smoking cessation...
  22. ncbi request reprint Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline
    Sharon M Hall
    University of California, San Francisco, San Francisco, CA 94143 0984, USA
    Nicotine Tob Res 9:467-71. 2007
    ....
  23. pmc Older versus younger treatment-seeking smokers: differences in smoking behavior, drug and alcohol use, and psychosocial and physical functioning
    Sharon M Hall
    University of California, San Francisco, San Francisco, CA 94143 0984, USA
    Nicotine Tob Res 10:463-70. 2008
    ..Implications for the assessment and treatment of older adults are discussed...
  24. ncbi request reprint Extended nortriptyline and psychological treatment for cigarette smoking
    Sharon M Hall
    University of California San Francisco, 401 Parnassus Ave, Box 0984, San Francisco, CA 94143 0984, USA
    Am J Psychiatry 161:2100-7. 2004
    ..Using a chronic disease model of smoking, the authors undertook a study to determine the effects of long-term antidepressant and psychological treatment...
  25. ncbi request reprint Influences of mood, depression history, and treatment modality on outcomes in smoking cessation
    Amie L Haas
    Department of Psychiatry, University of California, San Francisco, CA 94304, USA
    J Consult Clin Psychol 72:563-70. 2004
    ..The study replicated results reported by R. A. Brown et al. (2001) and expanded upon them by evaluating the differential contribution of poor mood on cessation outcomes relative to MDD history...
  26. ncbi request reprint Neurotransmitters, neurosteroids and neurotrophins: new models of the pathophysiology and treatment of depression
    Owen M Wolkowitz
    World J Biol Psychiatry 4:98-102. 2003
  27. ncbi request reprint Chronic pregnenolone effects in normal humans: attenuation of benzodiazepine-induced sedation
    Sharon E Meieran
    University of California, San Francisco School of Medicine, San Francisco, CA, USA
    Psychoneuroendocrinology 29:486-500. 2004
    ..Further larger-scale studies, utilizing a broader range of doses and experimental conditions, are warranted...
  28. ncbi request reprint Comorbidity of bipolar disorder and substance abuse in Costa Rica: pedigree- and population-based studies
    Michael A Escamilla
    Department of Psychiatry, 7792, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    J Affect Disord 71:71-83. 2002
    ....
  29. ncbi request reprint Behavioral implications of lowering cholesterol levels: a double-blind pilot study
    Tom Ormiston
    Santa Clara Valley Medical Center, San Jose, CA 95128, USA
    Psychosomatics 44:412-4. 2003
    ..This pilot study, although limited in size, raises the possibility that cholesterol-lowering drugs are associated with mild, time-limited increases in impulsivity and with mild, time-delayed improvements in depression ratings...
  30. ncbi request reprint Altering cortisol level does not change the pleasurable effects of methamphetamine in humans
    Debra S Harris
    Drug Dependence Research Center, Langley Porter Psychiatric Institute, Department of Psychiatry, University of California, San Francisco, CA 94143 0984, USA
    Neuropsychopharmacology 28:1677-84. 2003
    ..Metyrapone was associated with significant premature ventricular complexes in two subjects during methamphetamine administration and may not be safe for those who use methamphetamine...
  31. ncbi request reprint Psychological intervention and antidepressant treatment in smoking cessation
    Sharon M Hall
    Department of Psychiatry, University of California, San Francisco, 94143 0984, USA
    Arch Gen Psychiatry 59:930-6. 2002
    ..This study compared both drugs with placebo. It also examined the efficacy of these 2 drugs and placebo with and without psychological intervention...
  32. ncbi request reprint Double-blind antiglucocorticoid treatment in schizophrenia and schizoaffective disorder: a pilot study
    Elysa J Marco
    University of California, Langley Porter Psychiatric Institute, San Francisco, USA
    World J Biol Psychiatry 3:156-61. 2002
    ....
  33. pmc Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate
    Roel A Ophoff
    Neurogenetics Laboratory, University of California, San Francisco, CA, USA
    Am J Hum Genet 71:565-74. 2002
    ..This region could be important for severe psychiatric disorders, rather than for a specific phenotype...
  34. ncbi request reprint A comparative study of obsessive-compulsive disorder in Costa Rica and the United States
    Denise A Chavira
    Department of Psychiatry, University of California San Diego, San Diego, California 92037, USA
    Depress Anxiety 25:609-19. 2008
    ..However some features of OCD, such as impairment, may be culturally influenced, leading to differences in prevalence rates and treatment utilization...
  35. ncbi request reprint Benzodiazepines in schizophrenia: prefrontal cortex atrophy predicts clinical response to alprazolam augmentation
    William W Seeley
    Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
    World J Biol Psychiatry 3:221-4. 2002
    ..Mechanistic considerations and suggestions for future research are discussed...
  36. ncbi request reprint Tic symptom profiles in subjects with Tourette Syndrome from two genetically isolated populations
    Carol A Mathews
    Department of Psychiatry, University of California, San Diego, La Jolla, California 92093 0810, USA
    Biol Psychiatry 61:292-300. 2007
    ..Tourette Syndrome (TS) has a complex etiology and wide variability in phenotypic expression. Identifying underlying symptom patterns may be useful for etiological and outcome studies of TS...
  37. ncbi request reprint Genetic mapping using haplotype and model-free linkage analysis supports previous evidence for a locus predisposing to severe bipolar disorder at 5q31-33
    Kyung Sue Hong
    Center for Neurobehavioral Genetics, University of California Los Angeles, Los Angeles, California 90095 1761, USA
    Am J Med Genet B Neuropsychiatr Genet 125:83-6. 2004
    ..These results support the suggestion that a locus at 5q31-33, together with a previously reported locus at 18q22-23, may provide the major genetic risk for BP-I in this family...
  38. ncbi request reprint Genetic studies of neuropsychiatric disorders in Costa Rica: a model for the use of isolated populations
    Carol A Mathews
    Department of Psychiatry, University of California, San Diego, La Jolla, CA 92093 0810, USA
    Psychiatr Genet 14:13-23. 2004
    ..In this paper we highlight the studies currently being conducted by our groups in the Central Valley of Costa Rica to illustrate the potential advantages of this population for genetic studies...